Bargain or trap? US bank stock outlook hinges on Fed's path
By David Randall NEW YORK Bargain hunters are swirling around beaten-down shares of U.S. banks, even as skeptical
2023-11-11 06:15
Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits
The craze around pricey weight-loss drugs has many people clamoring for these treatments in company-sponsored health plans. While
2023-11-11 00:47
Old Mutual Asks Peers to Reject Sasol Climate Resolutions
Old Mutual Investment Managers plans to vote against a number of resolutions at the Nov. 17 annual general
2023-11-10 22:28
Novo to Build $6 Billion Plant as Obesity Drug Demand Surges
Novo Nordisk A/S will invest more than 42 billion kroner ($6 billion) to expand its manufacturing facilities as
2023-11-10 21:25
Ramsay, Sime Darby to Sell Hospital Unit for $1.2 Billion
Australia’s Ramsay Health Care Ltd. and Malaysian conglomerate Sime Darby Bhd. have agreed to sell their hospital unit
2023-11-10 19:53
An Opioid-Like Drink Is Masquerading As a Wholesome Alcohol Alternative
When Krista Marquick discovered kratom, it filled a hole in her life that quitting alcohol had left —
2023-11-10 18:51
Covid Loss of Smell Takes Up to Three Years to Return, Study Finds
The loss of taste and smell — hallmarks of a coronavirus infection early in the pandemic — became
2023-11-10 11:21
Novavax Plans to Cut Costs by Another $300 Million
Covid-19 vaccine maker Novavax Inc. slashed its sales forecast and said it’s ready to cut at least another
2023-11-09 23:54
Eli Lilly: still seeking UK approval on pen for weight-loss drug
By Maggie Fick and Ludwig Burger LONDON Eli Lilly on Thursday said it has not yet gained approval
2023-11-09 21:54
Weight loss drugs transforming healthcare, may help with addiction -Reuters Events
By Julie Steenhuysen and Caroline Stauffer CHICAGO A new class of weight loss drugs is transforming the U.S.
2023-11-09 19:29
Astra Enters Obesity Drug Race With Chinese Biotech Deal
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines, agreeing
2023-11-09 18:54
Merck KGaA Beats on Earnings Amid Demand for Cancer Drugs
Merck KGaA reported earnings that topped estimates as strong demand for cancer drugs Bavencio and Erbitux helped cushion
2023-11-09 14:17